Evidence mapPaperPMID 33072639Full record

ArticleAdvanced biomedical research2020

Prevalence of

Abdulbari Bener, Ahmet Faruk Ağan, Abdulla O A A Al-Hamaq, Cem Cahit Barisik, Mustafa Öztürk, Abdulkadir Ömer

Abstract read
In one paragraph

Article in Advanced biomedical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The Prevalence ofMedicina (Kaunas, Lithuania) · 2025
    Article
  3. Article
  4. Article
  5. Identification of hub genes associated withWorld journal of diabetes · 2024
    Article
  6. Article
  7. Review
  8. Children (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Microorganisms · 2021
    Review
  11. Review
  12. Gut Microbiota: The Missing Link BetweenFrontiers in endocrinology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdulbari BenerDepartment of Biostatistics and Medical Informatics, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Ahmet Faruk AğanDepartment of Gastroenterology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Abdulla O A A Al-HamaqQatar Diabetic Associations and Qatar Foundation, Doha, Qatar.
Cem Cahit BarisikDepartment of Raiology and Pathology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Mustafa ÖztürkDepartment of Endocrinology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Abdulkadir ÖmerDepartment of Endocrinology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral conducted studies have reported a higher and more frequent MATERIALS AND

methodsA case and control study was conducted based on 529 T2DM patients and 529 control.

resultsThe findings showed a positive significantly higher antibody titer for

conclusionsThe current study revealed that

Indexed as

Diabetesglycosylated hemoglobinHelicobacter pylori infectionimmunoglobulinimmunoglobulin Aimmunoglobulin G

Identifiers

PMID33072639
PMCPMC7532836

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.